Yunzhao Chen
Beijing Normal University(CN)Tianjin Medical University General Hospital(CN)Zhejiang Cancer Hospital(CN)Binzhou People's Hospital(CN)Inner Mongolia People's Hospital(CN)State Key Joint Laboratory of Environment Simulation and Pollution Control(CN)Zhejiang Provincial People's Hospital(CN)Hangzhou Medical College(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, RNA modifications and cancer, Cancer-related Molecular Pathways, Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation
Most-Cited Works
- → Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression(2019)476 cited
- → Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy(2020)237 cited
- → Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP(2019)105 cited
- → Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma(2017)72 cited
- → Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt/β-catenin signaling(2017)60 cited
- → PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma